Skip to main content
Premium Trial:

Request an Annual Quote

Adel Mahmoud

Premium
Becton Dickinson said this week that it has elected Adel Mahmoud to its board of directors.
 
Mahmoud has been named the chief executive of the Global HIV Vaccine Enterprise, effective Sept. 1. He is currently chief medical advisor, vaccines and infectious diseases for Merck. From 1999 to 2005, Mahmoud served as president of Merck Vaccines and as a member of the management committee. He holds an MD from the University of Cairo and a DPH from the University of Ain Shams, and a PhD from the University of London’s School of Hygiene and Tropical Medicine.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.